Atherosclerosis induced by chlamydophila pneumoniae: A controversial theory

Interdisciplinary Perspectives on Infectious Diseases

Volumn 2013, Issue , 2013, Pages

  Honarmand, Hamidreza ^a  

^a GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; MACROLIDE;

ANTIBIOTIC THERAPY; ATHEROMA; ATHEROSCLEROSIS; BACTERIUM CULTURE; CHLAMYDIAL PNEUMONIA; CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; ELECTRON MICROSCOPY; ENZYME IMMUNOASSAY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; REVIEW;

EID: 84881414876     PISSN: 1687708X     EISSN: 16877098     Source Type: Journal    
DOI: 10.1155/2013/941392     Document Type: Review

References (111)

1. Watson C., Alp N. J., Role of Chlamydia pneumoniae in atherosclerosis. Clinical Science 2008 114 7-8 509 531 2-s2.0-41949084224 10.1042/CS20070298 (Pubitemid 351548759)
2. Alpert P. T., New and emerging theories of cardiovascular disease: infection and elevated iron. Biological Research for Nursing 2004 6 1 3 10 2-s2.0-3843097333 10.1177/1099800404264777 (Pubitemid 44005148)
3. Fong I. W., Emerging relations between infectious diseases and coronary artery disease and atherosclerosis. Canadian Medical Association Journal 2000 163 1 49 56 2-s2.0-0034636758 (Pubitemid 30490322)
4. Zebrack J. S., Anderson J. L., The role of infection in the pathogenesis of cardiovascular disease. Progress in Cardiovascular Nursing 2003 18 1 42 49 2-s2.0-0037645313
5. Fong I. W., New perspectives of infections in cardiovascular disease. Current Cardiology Reviews 2009 5 2 87 104 2-s2.0-68549088946 10.2174/157340309788166679
6. Fong I. W., Infections and the Cardiovascular System: New Perspectives 2003 New York, NY, USA Kluwer Academic/Plenum Publishers Chlamydia Pneumoniae and the Cardiovascular System
7. Fong I. W., Infections and the Cardiovascular System: New Perspectives 2003 New York, NY, USA Kluwer Academic/Plenum Publishers Periodontal Disease and the Cardiovascular System
8. Strong J. P., Malcom G. T., McMahan C. A., Tracy R. E., Newman W. P. III, Herderick E. E., Cornhill J. F., Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the pathobiological determinants of atherosclerosis in youth study. Journal of the American Medical Association 1999 281 8 727 735 2-s2.0-0033599278 10.1001/jama.281.8.727 (Pubitemid 29113454)
9. Grayston J. T., Infections caused by Chlamydia pneumoniae strain TWAR. Clinical Infectious Diseases 1992 15 5 757 763 2-s2.0-0026464745
10. Sessa R., Nicoletti M., Di Pietro M., Schiavoni G., Santino I., Zagaglia C., Del Piano M., Cipriani P., Chlamydia pneumoniae and atherosclerosis: current state and future prospectives. International Journal of Immunopathology and Pharmacology 2009 22 1 9 14 2-s2.0-62649083251
11. Fong I. W., Chiu B., Viira E., Tucker W., Wood H., Peeling R. W., Chlamydial heat-shock protein-60 antibody and correlation with Chlamydia pneumoniae in atherosclerotic plaques. Journal of Infectious Diseases 2002 186 10 1469 1473 2-s2.0-0037111089 10.1086/344730 (Pubitemid 35286115)
12. Fong I. W., Chiu B., Viira E., Jang D., Mahony J. B., De novo induction of atherosclerosis by Chlamydia pneumoniae in a rabbit model. Infection and Immunity 1999 67 11 6048 6055 2-s2.0-0032750520 (Pubitemid 29508136)
13. Li L., Messas E., Batista E. L. Jr., Levine R. A., Amar S., Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation 2002 105 7 861 867 2-s2.0-0037133346 10.1161/hc0702.104178 (Pubitemid 34174928)
14. Vehmaan-Kreula P., Puolakkainen M., Sarvas M., Welgus H. G., Kovanen P. T., Chlamydia pneumoniae proteins induce secretion of the 92-kDa gelatinase by human monocyte-derived macrophages. Arteriosclerosis, Thrombosis, and Vascular Biology 2001 21 1 E1 E8 2-s2.0-0035227175
15. Schmidt R., Redecke V., Breitfeld Y., Wantia N., Miethke T., Massberg S., Fischel S., Neuman F.-J., Schömig A., May A. E., EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae -infected monocytes. Implications for plaque rupture. Thrombosis and Haemostasis 2006 95 1 151 158 2-s2.0-33645553116 10.1007/3-540-31304-4-12
16. Dechend R., Maass M., Gieffers J., Dietz R., Scheidereit C., Leutz A., Gulba D. C., Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF- b and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis. Circulation 1999 100 13 1369 1373 2-s2.0-0033613066 (Pubitemid 29451694)
17. Muhlestein J. B., Anderson J. L., Hammond E. H., Zhao L., Trehan S., Schwobe E. P., Carlquist J. F., Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 1998 97 7 633 636 2-s2.0-0032562148 (Pubitemid 28090954)
18. Fong I. W., Chiu B., Viira E., Jang D., Fong M. W., Peeling R., Mahony J. B., Can an antibiotic (Macrolide) prevent Chlamydia pneumoniae -induced atherosclerosis in a rabbit model? Clinical and Diagnostic Laboratory Immunology 1999 6 6 891 894 2-s2.0-0032733118 (Pubitemid 29529984)
19. Kutlin A., Roblin P. M., Hammerschlag M. R., In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection model. Antimicrobial Agents and Chemotherapy 1999 43 9 2268 2272 2-s2.0-0032845190 (Pubitemid 29421213)
20. Wolf K., Malinverni R., Effect of azithromycin plus rifampin versus that of azithromycin alone on the eradication of Chlamydia pneumoniae from lung tissue in experimental pneumonitis. Antimicrobial Agents and Chemotherapy 1999 43 6 1491 1493 2-s2.0-0033067071 (Pubitemid 29259351)
21. Gieffers J., Füllgraf H., Jahn J., Klinger M., Dalhoff K., Katus H. A., Solbach W., Maass M., Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment. Circulation 2001 103 3 351 356 2-s2.0-0035936544 (Pubitemid 32105972)
22. Dechend R., Gieffers J., Dietz R., Joerres A., Rupp J., Luft F. C., Maass M., Hydroxymethylglutaryl coenzyme A reductase inhibition reduces Chlamydia pneumoniae -induced cell interaction and activation. Circulation 2003 108 3 261 265 2-s2.0-0041807643 10.1161/01.CIR.0000083367.93022.78 (Pubitemid 36899013)
23. Schmeck B., Beermann W., Dje N'Guessan P., Hocke A. C., Opitz B., Eitel J., Dinh Q. T., Witzenrath M., Krüll M., Suttorp N., Hippenstiel S., Simvastatin reduces Chlamydophila pneumoniae -mediated histone modifications and gene expression in cultured human endothelial cells. Circulation Research 2008 102 8 888 895 2-s2.0-42549129871 10.1161/CIRCRESAHA.107.161307 (Pubitemid 351591545)
24. Liuba P., Pesonen E., Forslid A., Paakkari I., Kornerup-Hansen A., Kovanen P., Pentikäinen M., Persson K., Østergård G., Protective effects of simvastatin on coronary artery function in swine with acute infection. Atherosclerosis 2006 186 2 331 336 2-s2.0-33646413138 10.1016/j.atherosclerosis.2005.08.017
25. Hu H., Pierce G. N., Zhong G., The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. Journal of Clinical Investigation 1999 103 5 747 753 2-s2.0-0033105576 (Pubitemid 29122429)
26. Dunne M., The evolving relationship between Chlamydia pneumoniae and atherosclerosis. Current Opinion in Infectious Diseases 2000 13 6 583 591 2-s2.0-0033668181
27. Danesh J., Collins R., Peto R., Chronic infections and coronary heart disease: is there a link? The Lancet 1997 350 9075 430 436 2-s2.0-0030757024 10.1016/S0140-6736(97)03079-1 (Pubitemid 27331246)
28. Ossewaarde J. M., Feskens E. J. M., De Vries A., Vallinga C. E., Kromhout D., Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not. Epidemiology and Infection 1998 120 1 93 99 2-s2.0-0031884191 10.1017/S0950268897008303 (Pubitemid 28130026)
29. Maass M., Gieffers J., Cardiovascular disease risk from prior Chlamydia pneumoniae infection can be related to certain antigens recognized in the immunoblot profile. Journal of Infection 1997 35 2 171 176 2-s2.0-0030707937 10.1016/S0163-4453(97)91743-6 (Pubitemid 27464688)
30. Fagerberg B., Gnarpe J., Gnarpe H., Agewall S., Wikstrand J., Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: a prospective study in middle-aged to elderly men with treated hypertension. Stroke 1999 30 2 299 305 2-s2.0-0032934397 (Pubitemid 29071793)
31. Miyashita N., Toyota E., Sawayama T., Matsumoto A., Mikami Y., Kawai N., Takada K., Niki Y., Matsushima T., Association of chronic infection of Chlamydia pneumoniae and coronary heart disease in the Japanese. Internal Medicine 1998 37 11 913 916 2-s2.0-0032197183 (Pubitemid 128520908)
32. Thomas G. N., Scheel O., Koehler A. P., Bassett D. C. J., Cheng A. F. B., Respiratory chlamydial infections in a Hong Kong teaching hospital and association with coronary heart disease. Scandinavian Journal of Infectious Diseases, Supplement 1997 104 30 33 2-s2.0-0030611319
33. Cook P. J., Honeybourne D., Lip G. Y. H., Beevers D. G., Wise R., Davies P., Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project. Stroke 1998 29 2 404 410 2-s2.0-0031908517 (Pubitemid 28086683)
34. Strachan D. P., Carrington D., Mendall M. A., Ballam L., Morris J., Butland B. K., Sweetnam P. M., Elwood P. C., Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the Caerphilly prospective heart disease study. British Medical Journal 1999 318 7190 1035 1040 2-s2.0-0033577551 (Pubitemid 29191891)
35. Ridker P. M., Kundsin R. B., Stampfer M. J., Poulin S., Hennekens C. H., Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction. Circulation 1999 99 9 1161 1164 2-s2.0-0033537632 (Pubitemid 29120087)
36. Laurila A., Bloigu A., Näyhä S., Hassi J., Leinonen M., Saikku P., Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 1997 17 11 2910 2913 2-s2.0-0031457557 (Pubitemid 28016041)
37. Berger M., Schröder B., Daeschlein G., Schneider W., Busjahn A., Buchwalow I., Luft F. C., Haller H., Chlamydia pneumoniae DNA in non-coronary atherosclerotic plaques and circulating leukocytes. Journal of Laboratory and Clinical Medicine 2000 136 3 194 200 2-s2.0-0033806948 10.1067/mlc.2000.108941
38. Dowell S. F., Peeling R. W., Boman J., Carlone G. M., Fields B. S., Guarner J., Hammerschlag M. R., Jackson L. A., Kuo C.-C., Maass M., Messmer T. O., Talkington D. F., Tondella M. L., Zaki S. R., Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clinical Infectious Diseases 2001 33 4 492 502 2-s2.0-0035882178 10.1086/322632 (Pubitemid 32709582)
39. Tiirola T., Sinisalo J., Nieminen M. S., Silvennoinen-Kassinen S., Paldanius M., Saikku P., Jauhiainen M., Leinonen M., Chlamydial lipopolysaccharide is present in serum during acute coronary syndrome and correlates with CRP levels. Atherosclerosis 2007 194 2 403 407 2-s2.0-34948842035 10.1016/j.atherosclerosis.2006.08.013 (Pubitemid 47520617)
40. Gurfinkel E., Bozovich G., Daroca A., Beck E., Mautner B., Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. The Lancet 1997 350 9075 404 407 2-s2.0-0030845069 10.1016/S0140-6736(97)07201-2 (Pubitemid 27331235)
41. Gupta S., Leatham E. W., Carrington D., Mendall M. A., Kaski J. C., Camm A. J., Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 1997 96 2 404 407 2-s2.0-0030803032 (Pubitemid 27329411)
42. Gurfinkel E., Bozovich G., Beck E., Testa E., Livellara B., Mautner B., Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS study. European Heart Journal 1999 20 2 121 127 2-s2.0-0032968428 10.1053/euhj.1998.1283 (Pubitemid 29049693)
43. Mahdi O. S., Horne B. D., Mullen K., Muhlestein J. B., Byrne G. I., Serum immunoglobulin G antibodies to chlamydial heat shock protein 60 but not to human and bacterial homologs are associated with coronary artery disease. Circulation 2002 106 13 1659 1663 2-s2.0-0037167716 10.1161/01.CIR.0000031567. 10814.D8
44. Hogan R. J., Mathews S. A., Mukhopadhyay S., Summersgill J. T., Timms P., Chlamydial persistence: beyond the biphasic paradigm. Infection and Immunity 2004 72 4 1843 1855 2-s2.0-1842432037 10.1128/IAI.72.4.1843-1855.2004 (Pubitemid 38419894)
45. Borel N., Summersgill J. T., Mukhopadhyay S., Miller R. D., Ramirez J. A., Pospischil A., Evidence for persistent Chlamydia pneumoniae infection of human coronary atheromas. Atherosclerosis 2008 199 1 154 161 2-s2.0-45249114643 10.1016/j.atherosclerosis.2007.09.026 (Pubitemid 351842691)
46. Bunk S., Susnea I., Rupp J., Summersgill J. T., Maass M., Stegmann W., Schrattenholz A., Wendel A., Przybylski M., Hermann C., Immunoproteomic identification and serological responses to novel Chlamydia pneumoniae antigens that are associated with persistent C. pneumoniae infections. Journal of Immunology 2008 180 8 5490 5498 2-s2.0-45949086517
47. Boman J., Söderberg S., Forsberg J., Birgander L. S., Allard A., Persson K., Jidell E., Kumlin U., Juto P., Waldenström A., Wadell G., High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. Journal of Infectious Diseases 1998 178 1 274 277 2-s2.0-17344369195 (Pubitemid 28328107)
48. Wong Y.-K., Dawkins K. D., Ward M. E., Circulating Chlamydia pneumoniae DNA as a predictor of coronary artery disease. Journal of the American College of Cardiology 1999 34 5 1435 1439 2-s2.0-0033231396 10.1016/S0735-1097(99)00391- 5 (Pubitemid 29528654)
49. Ross R., The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993 362 6423 801 809 2-s2.0-0027241856 10.1038/362801a0 (Pubitemid 23132154)
50. Ward M. E., The immunobiology and immunopathology of chlamydial infections. APMIS 1995 103 11 769 796 2-s2.0-0029585758 (Pubitemid 26008846)
51. Saikku P., Chlamydia pneumoniae infection as a risk factor in acute myocardial infarction. European Heart Journal 1993 14 62 65 2-s2.0-0027732286 (Pubitemid 24038956)
52. Brown M. S., Goldstein J. L., Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annual Review of Biochemistry 1983 52 223 261 2-s2.0-0020972414 (Pubitemid 13030685)
53. Kalayoglu M. V., Byrne G. I., Induction of macrophage foam cell formation by Chlamydia pneumoniae. Journal of Infectious Diseases 1998 177 3 725 729 2-s2.0-0031912008 (Pubitemid 28099889)
54. Kalayoglu M. V., Byrne G. I., A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide. Infection and Immunity 1998 66 11 5067 5072 2-s2.0-0032443223 (Pubitemid 29044592)
55. Campbell L. A., O'Brien E. R., Cappuccio A. L., Kuo C.-C., Wang S.-P., Stewart D., Patton D. L., Cummings P. K., Grayston J. T., Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. Journal of Infectious Diseases 1995 172 2 585 588 2-s2.0-0029089895
56. Kuo C.-C., Shor A., Campbell L. A., Fukushi H., Patton D. L., Grayston J. T., Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. Journal of Infectious Diseases 1993 167 4 841 849 2-s2.0-0027406611 (Pubitemid 23088253)
57. Ramirez J. A., Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Annals of Internal Medicine 1996 125 12 979 982 2-s2.0-0030479814 (Pubitemid 26424527)
58. Leinonen M., Kerttula Y., Weber T., Saikku P., Acute phase response in Chlamydia pneumoniae pneumonia. Abstracts of the 5th European Congress on Clinical Microbiology and Infectious Diseases September 1991 Oslo, Norway 86
59. Laurila A., Bloigu A., Näyhä S., Hassi J., Leinonen M., Saikku P., Chlamydia pneumoniae antibodies and serum lipids in Finnish men: cross sectional study. British Medical Journal 1997 314 7092 1456 1457 2-s2.0-0030962360 (Pubitemid 27207937)
60. Cabana V. G., Siegel J. N., Sabesin S. M., Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins. Journal of Lipid Research 1989 30 1 39 49 2-s2.0-0024575115 (Pubitemid 19037564)
61. Feingold K. R., Hardardottir I., Memon R., Krul E. J. T., Moser A. H., Taylor J. M., Grunfeld C., Effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters. Journal of Lipid Research 1993 34 12 2147 2158 2-s2.0-0027135157 (Pubitemid 24000962)
62. Auerbach B. J., Parks J. S., Lipoprotein abnormalities associated with lipopolysaccharide-induced lecithin:cholesterol acyltransferase and lipase deficiency. Journal of Biological Chemistry 1989 264 17 10264 10270 2-s2.0-0024361642 (Pubitemid 19159299)
63. Ly H., Francone O. L., Fielding C. J., Shigenaga J. K., Moser A. H., Grunfeld C., Feingold K. R., Endotoxin and TNF lead to reduced plasma LCAT activity and decreased hepatic LCAT mRNA levels in Syrian hamsters. Journal of Lipid Research 1995 36 6 1254 1263 2-s2.0-0029044094
64. Feingold K. R., Grunfeld C., Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. Journal of Clinical Investigation 1987 80 1 184 190 2-s2.0-0023220709 (Pubitemid 17097532)
65. Feingold K. R., Pollock A. S., Moser A. H., Shigenaga J. K., Grunfeld C., Discordant regulation of proteins of cholesterol metabolism during the acute phase response. Journal of Lipid Research 1995 36 7 1474 1482 2-s2.0-0029113729
66. Galdiero M., De L'Ero G. C., Marcatili A., Cytokine and adhesion molecule expression in human monocytes and endothelial cells stimulated with bacterial heat shock proteins. Infection and Immunity 1997 65 2 699 707 2-s2.0-0031030347 (Pubitemid 27053983)
67. Kol A., Sukhova G. K., Lichtman A. H., Libby P., Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor- and matrix metalloproteinase expression. Circulation 1998 98 4 300 307 2-s2.0-0032575305 (Pubitemid 28348051)
68. Gaydos C. A., Summersgill J. T., Sahney N. N., Ramirez J. A., Quinn T. C., Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infection and Immunity 1996 64 5 1614 1620 2-s2.0-0029877045 (Pubitemid 26129824)
69. Godzik K. L., O'Brien E. R., Wang S.-K., Kuo C.-C., In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. Journal of Clinical Microbiology 1995 33 9 2411 2414 2-s2.0-0029132190
70. Kaukoranta-Tolvanen S.-S. E., Ronni T., Leinonen M., Saikku P., Laitinen K., Expression of adhesion molecules on endothelial cell stimulated by Chlamydia pneumoniae. Microbial Pathogenesis 1996 21 5 407 411 2-s2.0-0030297684 10.1006/mpat.1996.0071 (Pubitemid 26387324)
71. Molestina R. E., Dean D., Miller R. D., Ramirez J. A., Summersgill J. T., Characterization of a strain of Chlamydia pneumoniae isolated from a coronary atheroma by analysis of the omp1 gene and biological activity in human endothelial cells. Infection and Immunity 1998 66 4 1370 1376 2-s2.0-0032038662 (Pubitemid 128471492)
72. Heinemann M., Susa M., Simnacher U., Marre R., Essig A., Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line. Infection and Immunity 1996 64 11 4872 4875 2-s2.0-0029973925 (Pubitemid 26357108)
73. Beatty W. L., Byrne G. I., Morrison R. P., Morphologic and antigenic characterization of interferon γ -mediated persistent Chlamydia trachomatis infection in vitro. Proceedings of the National Academy of Sciences of the United States of America 1993 90 9 3998 4002 2-s2.0-0027285841 (Pubitemid 23134153)
74. Xu Q., Dietrich H., Steiner H. J., Gown A. M., Schoel B., Mikuz G., Kaufmann S. H. E., Wick G., Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arteriosclerosis and Thrombosis 1992 12 7 789 799 2-s2.0-0026683392
75. Wick G., Kleindienst R., Schett G., Amberger A., Xu Q., Role of heat shock protein 65/60 in the pathogenesis of atherosclerosis. International Archives of Allergy and Immunology 1995 107 1-3 130 131 2-s2.0-0029015527
76. Xu Q., Willeit J., Marosi M., Kleindienst R., Oberhollenzer F., Kiechl S., Stulnig T., Luef G., Wick G., Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. The Lancet 1993 341 8840 255 259 2-s2.0-0027399854 10.1016/0140-6736(93)92613-X (Pubitemid 23038021)
77. Hoppichler F., Lechleitner M., Traweger C., Schett G., Dzien A., Sturm W., Qingbo X., Changes of serum antibodies to heat-shock protein 65 in coronary heart disease and acute myocardial infarction. Atherosclerosis 1996 126 2 333 338 2-s2.0-0030601721 10.1016/0021-9150(96)05931-X (Pubitemid 26336670)
78. Schett G., Xu Q., Amberger A., Van der Zee R., Recheis H., Willeit J., Wick G., Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. Journal of Clinical Investigation 1995 96 6 2569 2577 2-s2.0-0028809489
79. Xu Q., Schett G., Seitz C. S., Hu Y., Gupta R. S., Wick G., Surface staining and cytotoxic activity of heat-shock protein 60 antibody in stressed aortic endothelial cells. Circulation Research 1994 75 6 1078 1085 2-s2.0-0028027413 (Pubitemid 24351453)
80. Schett G., Metzler B., Mayr M., Amberger A., Niederwieser D., Gupta R. S., Mizzen L., Xu Q., Wick G., Macrophage-lysis mediated by autoantibodies to heat shock protein 65/60. Atherosclerosis 1997 128 1 27 38 2-s2.0-0031044403 10.1016/S0021-9150(96)05975-8 (Pubitemid 27065258)
81. Jackson L. A., Campbell L. A., Schmidt R. A., Kuo C.-C., Cappuccio A. L., Lee M. J., Grayston J. T., Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis. American Journal of Pathology 1997 150 5 1785 1790 2-s2.0-0030894713 (Pubitemid 27193824)
82. Kaukoranta-Tolvanen S.-S., Laitinen K., Saikku P., Leinonen M., Chlamydia pneumoniae multiplies in human endothelial cells in vitro. Microbial Pathogenesis 1994 16 4 313 319 2-s2.0-0027930864 10.1006/mpat.1994.1032 (Pubitemid 24253076)
83. Kaukoranta-Tolvanen S.-S. E., Teppo A.-M., Laitinen K., Saikku P., Linnavuori K., Leinonen M., Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response. Microbial Pathogenesis 1996 21 3 215 221 2-s2.0-0030246949 10.1006/mpat.1996. 0056 (Pubitemid 26290572)
84. Frenette P. S., Wagner D. D., Molecular medicine adhesion molecules-part I. The New England Journal of Medicine 1996 334 23 1526 1529 2-s2.0-0030572184 10.1056/NEJM199606063342308 (Pubitemid 26166897)
85. Frenette P. S., Wagner D. D., Adhesion molecules-part II: blood vessels and blood cells. The New England Journal of Medicine 1996 335 1 43 45 2-s2.0-0029901701 10.1056/NEJM199607043350108 (Pubitemid 26230813)
86. Beatty W. L., Morrison R. P., Byrne G. I., Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiological Reviews 1994 58 4 686 699 2-s2.0-0027946866
87. Young R. A., Elliott T. J., Stress proteins, infection, and immune surveillance. Cell 1989 59 1 5 8 2-s2.0-0024418447 (Pubitemid 19248553)
88. Geng Y.-J., Regulation of programmed cell death or apoptosis in atherosclerosis. Heart and Vessels 1997 12 12 76 80 2-s2.0-0031283332 (Pubitemid 28017740)
89. Mitchinson M. J., Hardwick S. J., Bennett M. R., Cell death in atherosclerotic plaques. Current Opinion in Lipidology 1996 7 5 324 329 2-s2.0-0029852550 (Pubitemid 26372453)
90. Kol A., Bourcier T., Lichtman A. H., Libby P., Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. Journal of Clinical Investigation 1999 103 4 571 577 2-s2.0-0033557202 (Pubitemid 29094058)
91. Steinberg D., Oxidative modification of LDL and atherogenesis. Circulation 1997 95 4 1062 1071 2-s2.0-0031048299
92. Steinberg D., Low density lipoprotein oxidation and its pathobiological significance. Journal of Biological Chemistry 1997 272 34 20963 20966 2-s2.0-0030799043 10.1074/jbc.272.34.20963 (Pubitemid 27373946)
93. Hessler J. R., Morel D. W., Lewis L. J., Chisolm G. M., Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis 1983 3 3 215 222 2-s2.0-0020621415 (Pubitemid 13099583)
94. Henriksen T., Mahoney E. M., Steinberg D., Interactions of plasma lipoproteins with endothelial cells. Annals of the New York Academy of Sciences 1982 401 102 116 2-s2.0-0020391349
95. Cushing S. D., Berliner J. A., Valente A. J., Territo M. C., Navab M., Parhami F., Gerrity R., Schwartz C. J., Fogelman A. M., Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proceedings of the National Academy of Sciences of the United States of America 1990 87 13 5134 5138 2-s2.0-0025281588 10.1073/pnas.87.13.5134 (Pubitemid 20224287)
96. Berliner J. A., Heinecke J. W., The role of oxidized lipoproteins in atherogenesis. Free Radical Biology and Medicine 1996 20 5 707 727 2-s2.0-0029883764 10.1016/0891-5849(95)02173-6 (Pubitemid 26105783)
97. Yla-Herttuala S., Palinski W., Rosenfeld M. E., Steinberg D., Witztum J. L., Lipoproteins in normal and atherosclerotic aorta. European Heart Journal 1990 11 88 99 2-s2.0-0025040177 (Pubitemid 20287945)
98. Stephens N. G., Parsons A., Schofield P. M., Kelly F., Cheeseman K., Mitchinson M. J., Brown M. J., Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). The Lancet 1996 347 9004 781 786 2-s2.0-0029925181 10.1016/S0140-6736(96)90866-1 (Pubitemid 26091640)
99. Chatterjee S., Ghosh N., Oxidized low density lipoprotein stimulates aortic smooth muscle cell proliferation. Glycobiology 1996 6 3 303 311 2-s2.0-0029970074 10.1093/glycob/6.3.303 (Pubitemid 26156450)
100. Terkeltaub R., Banka C. L., Solan J., Santoro D., Brand K., Curtiss L. K., Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity. Arteriosclerosis and Thrombosis 1994 14 1 47 53 2-s2.0-0028177460
101. Tosi M. F., Hammerschlag M. R., Chlamydia trachomatis selectively stimulates myeloperoxidase release but not superoxide production in human neutrophils. Journal of Infectious Diseases 1988 158 2 457 460 2-s2.0-0023683727
102. Heinecke J. W., Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis. Current Opinion in Lipidology 1997 8 5 268 274 2-s2.0-0030729868 (Pubitemid 27462433)
103. Cathcart M. K., McNally A. K., Chisolm G. M., Lipoxygenase-mediated transformation of human low density lipoprotein to an oxidized and cytotoxic complex. Journal of Lipid Research 1991 32 1 63 70 2-s2.0-0025966617
104. Aviram M., Rosenblat M., Etzioni A., Levy R., Activation of NADPH oxidase is required for macrophage-mediated oxidation of low-density lipoprotein. Metabolism: Clinical and Experimental 1996 45 9 1069 1079 2-s2.0-0029783343 10.1016/S0026-0495(96)90005-0 (Pubitemid 26300305)
105. Graham A., Wood J. L., O'Leary V., Stone D., Human (THP-1) macrophages oxidize LDL by a thiol-dependent mechanism. Free Radical Research 1994 25 2 181 192 2-s2.0-0030202665
106. Heinecke J. W., Rosen H., Chait A., Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. Journal of Clinical Investigation 1984 74 5 1890 1894 2-s2.0-0021721459 (Pubitemid 15214102)
107. Li Q., Subbulakshmi V., Fields A. P., Murray N. R., Cathcart M. K., Protein kinase C regulates human monocyte O2•̄ production and low density lipoprotein lipid oxidation. Journal of Biological Chemistry 1999 274 6 3764 3771 2-s2.0-0033524505 10.1074/jbc.274.6.3764 (Pubitemid 29077224)
108. Kukielka G. L., Youker K. A., Hawkins H. K., Perrard J. L., Michael L. H., Ballantyne C. M., Smith C. W., Entman M. L., Regulation of ICAM-1 and IL-6 in myocardial ischemia: effect of reperfusion. Annals of the New York Academy of Sciences 1994 723 258 270 2-s2.0-0028306197 10.1111/j.1749-6632.1994.tb36732.x (Pubitemid 24228150)
109. Seino Y., Ikeda U., Ikeda M., Yamamoto K., Misawa Y., Hasegawa T., Kano S., Shimada K., Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions. Cytokine 1994 6 1 87 91 2-s2.0-0028261395 10.1016/1043-4666(94)90013-2 (Pubitemid 24120205)
110. Yazdani S., Simon A. D., Vidhun R., Gulotta C., Schwartz A., Rabbani L. E., Inflammatory profile in unstable angina versus stable angina in patients undergoing percutaneous interventions. American Heart Journal 1998 136 2 357 361 2-s2.0-0031871091 10.1053/hj.1998.v136.90408 (Pubitemid 28368862)
111. Hansson G. K., Immunological control mechanisms in plaque formation. Basic Research in Cardiology 1994 89 supplement 1 41 46 2-s2.0-0027945646 (Pubitemid 24314596)